Table of Content

1 Relevant Concepts of Ustekinumab
1.1 Indications for Ustekinumab
1.2 Development of Ustekinumab in China
1.3 Governmental Approval of Ustekinumab in China
1.4 The Impact of COVID-19 on Ustekinumab sales in China


2 Sales of Ustekinumab in China, 2019-2020
2.1 Sales Value of Ustekinumab
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Ustekinumab
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Regions
2.3 Sales of Ustekinumab by Dosage Form in China, 2019-2020
2.3.1 Injection
2.3.2 Analysis of Other Dosage Forms


3 Analysis of Major Ustekinumab Manufacturers in China, 2019-2020
3.1 Analysis of Market Share of Major Ustekinumab Manufacturers
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales volume
3.2 Janssen-Cilag International NV (BE)
3.2.1 Enterprise Profile
3.2.2 Sales of STELARA (Janssen’s Ustekinumab) in China


4 Prices of Ustekinumab for Different Manufacturers in China, 2020-2021
4.1 Janssen-Cilag International NV (BE) (STELARA)


5 Prospect of Chinese Ustekinumab drug Market, 2021-2025
5.1 Influential Factors of Chinese Ustekinumab Market Development
5.1.1 The Impact of COVID-19 on Chinese Ustekinumab Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend

List of Charts
Chart Patent Information About Ustekinumab Injection Registration in China
Chart Sales Value of Ustekinumab Injection over the World
Chart Sales Value of Ustekinumab Injection in China, 2019-2020
Chart Sales Value of Ustekinumab Injection in China by Regions, 2019-2020
Chart Sales Volume of Ustekinumab Injection in China, 2019-2020
Chart Sales Volume of Ustekinumab Injection in China by Regions, 2019-2020
Chart Market Share by Sales Value of Top Ustekinumab Manufacturers in China, 2019-2020
Chart Sales Value and Volume of STELARA in China, 2019-2020
Chart Referential Prices of STELARA in China, 2020-2021
Chart Forecast on Sales Value of Ustekinumab in China, 2021-2025
Chart Forecast on Sales Volume of Ustekinumab in China, 2021-2025